Pepdox
Studies
Peptides
Calculator
Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply. | Pepdox
Home
/
Search
/
PMID 42035774
Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply.
Lancet (London, England)
2026
PMID: 42035774
View on PubMed
DOI: 10.1016/S0140-6736(26)00706-3
Semaglutide
Authors
Deanfield, John; Emerson, Scott S; Rasmussen, Søren; Stensen, Signe; Lincoff, A Michael